[The mTOR inhibitor enhances chemosensitivity of androgen-independent prostate cancer cell line]. [electronic resource]
- Zhonghua nan ke xue = National journal of andrology Jul 2009
- 617-20 p. digital
Publication Type: English Abstract; Journal Article
1009-3591
Antineoplastic Agents--pharmacology Cell Cycle--drug effects Cell Line, Tumor Drug Therapy, Combination Humans Male Paclitaxel--pharmacology Prostatic Neoplasms--drug therapy Protein Kinase Inhibitors--pharmacology Sirolimus--analogs & derivatives